These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19293153)

  • 41. Regulation of the membrane attack complex of complement. Evidence that C8 gamma is not the target of homologous restriction factors.
    Davé SJ; Sodetz JM
    J Immunol; 1990 Apr; 144(8):3087-90. PubMed ID: 2324496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
    Li Y; Parks GD
    Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defining the CD59-C9 binding interaction.
    Huang Y; Qiao F; Abagyan R; Hazard S; Tomlinson S
    J Biol Chem; 2006 Sep; 281(37):27398-404. PubMed ID: 16844690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J; Gold D; LoVerde PT; Fishelson Z
    Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release.
    Gee AP; Boyle MD; Borsos T
    J Immunol; 1980 Apr; 124(4):1905-10. PubMed ID: 7365242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
    Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
    Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59.
    Hüsler T; Lockert DH; Kaufman KM; Sodetz JM; Sims PJ
    J Biol Chem; 1995 Feb; 270(8):3483-6. PubMed ID: 7533152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
    J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
    Sawant-Mane S; Piddlesden SJ; Morgan BP; Holers VM; Koski CL
    J Neuroimmunol; 1996 Sep; 69(1-2):63-71. PubMed ID: 8823377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluid-phase assembly of the membrane attack complex of complement.
    Silversmith RE; Nelsestuen GL
    Biochemistry; 1986 Feb; 25(4):841-51. PubMed ID: 3964648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blocking antibodies specific for human albumin interfere with the hemolytic activity of the membrane attack complex of complement.
    Houle JJ; Hoffmann EM
    Biochem Biophys Res Commun; 1994 Apr; 200(1):135-41. PubMed ID: 8166680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin.
    Deng J; Gold D; LoVerde PT; Fishelson Z
    Infect Immun; 2003 Nov; 71(11):6402-10. PubMed ID: 14573661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane.
    Hu VW; Esser AF; Podack ER; Wisnieski BJ
    J Immunol; 1981 Jul; 127(1):380-6. PubMed ID: 7240749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity after site-directed mutagenesis of CD59 on complement-mediated cytolysis.
    Zhu X; Gao M; Ren S; Wang Q; Lin C
    Cell Mol Immunol; 2008 Apr; 5(2):141-6. PubMed ID: 18445344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
    Schönermark S; Rauterberg EW; Shin ML; Löke S; Roelcke D; Hänsch GM
    J Immunol; 1986 Mar; 136(5):1772-6. PubMed ID: 2419413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Penetration of C8 and C9 in the C5b-9 complex across the erythrocyte membrane into the cytoplasmic space.
    Whitlow MB; Ramm LE; Mayer MM
    J Biol Chem; 1985 Jan; 260(2):998-1005. PubMed ID: 2857173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
    Ohkura K; Nagamune H; Kourai H
    Anticancer Res; 2004; 24(5C):3343-53. PubMed ID: 15515430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of complement functional efficiency by histidine-rich glycoprotein.
    Chang NS; Leu RW; Rummage JA; Anderson JK; Mole JE
    Blood; 1992 Jun; 79(11):2973-80. PubMed ID: 1375119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
    Tschopp J; Masson D; Schäfer S; Peitsch M; Preissner KT
    Biochemistry; 1988 May; 27(11):4103-9. PubMed ID: 2458130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.